Back to Results
First PageMeta Content
Mycology / Fungal diseases / Triazoles / Organofluorides / Alcohols / Coccidioidomycosis / Coccidioides / Voriconazole / Antifungal medication / Antifungals / Biology / Microbiology


IDSA GUIDELINES Coccidioidomycosis John N. Galgiani,1,2,3 Neil M. Ampel,1,2,3 Janis E. Blair,4 Antonino Catanzaro,5 Royce H. Johnson,6 David A. Stevens,7,8 and Paul L. Williams9 1
Add to Reading List

Document Date: 2010-07-07 02:23:57


Open Document

File Size: 97,85 KB

Share Result on Facebook

City

Tucson / Washington / Fresno / Washington / DC / Scottsdale / San Diego / /

Company

Shatsky SA. / Merck / Squibb / Sanofi / D.A.S. / Bayer / Aventis / Ogden / Lilly / Pfizer / Dupont / Cox / Enzon / Bristol Myers / Schering / Janssen / /

Country

United States / /

Currency

USD / /

/

Facility

9Kaiser Permanente Medical Center / /

IndustryTerm

meningitis treatment / /

MedicalCondition

cardiopulmonary disease / pulmonary coccidioidal infection / nonmeningeal disseminated coccidioidomycosis / localized acute pulmonary infections / extrapulmonary nonmeningeal coccidioidomycosis / extrapulmonary infection / Hydrocephalus / JE / bacterial superinfection / experimental murine coccidioidomycosis / coccidioidal meningitis / osteomyelitis / disseminated nonmeningeal coccidioidomycosis / CNS vasculitis / Catanzaro A. Coccidioidomycosis / clinical disease / nonmeningeal coccidioidomycosis / refractory infections / progressive coccidioidomycosis / regional disease / latent infections / persistent headaches / illness / endemic mycoses / Coccidioides immitis meningitis / fungal infections / invasive aspergillosis / pulmonary coccidioidomycosis / Diffuse pneumonia / clinically apparent coccidioidal infection / pneumonia / pulmonary infiltrates / significant hemoptysis / cancer / experimental coccidioidal infections / respiratory failure / exceptionally severe primary infections / progressive pulmonary destruction / abscesses / Delayed-type hypersensitivity / Coccidioides meningitis / superinfection / chronic coccidioidal meningitis / coccidioidal infection / opportunistic infection / coccidioidal pneumonia / GUIDELINES Coccidioidomycosis John N. Galgiani / concurrent fungemia / AIDS / MANAGEMENT OF CLINICAL ENTITIES Primary Respiratory Infection Primary infections / infection / patient’s illness / human immunodeficiency virus infection / uncomplicated community-acquired pneumonia / pulmonary cavities / disseminated infections / severe vomiting / epidural abscess / Uncomplicated acute coccidioidal pneumonia / lymphoma / active coccidioidomycosis / diffuse coccidioidal pneumonia / primary respiratory coccidioidal infections / fungemia / murine coccidioidomycosis / chronic presentations / pericardial effusion / chronic pulmonary and nonmeningeal disseminated coccidioidomycosis / mild respiratory syndrome / hemoptysis / mild illness / primary infection / symptomatic chronic pulmonary and extrapulmonary disseminated infections / Disseminated Infection / community-acquired pneumonia / rapidly progressive coccidioidal infections / MS / residual pulmonary sequelae / severe pneumonia / infections / clinically active coccidioidomycosis / early infections / subacute community-acquired pneumonia / disseminated coccidioidomycosis / disease / bone tumor / deep mycoses / cerebral ischemia / coexistent diseases / primary infections / Primary pulmonary coccidioidomycosis / pulmonary lesions / disseminated disease / refractory coccidioidal infections / Clinical Infectious Diseases / diabetes mellitus / initial uncomplicated pulmonary infections / coccidioidomycosis / individual infections / chronic refractory coccidioidomycosis / progressive / nonmeningeal coccidioidomycosis / meningitis / patient’s infection / /

MedicalTreatment

anti- fungal therapy / surgery / oral therapy / immunosuppression / drainage / antifungal therapies / HAART / renal replacement therapy / renal transplant / lobectomy / alternative therapy / invasive procedures / antifungal therapy / organ transplant / drug therapy / /

Organization

8Stanford University / San Jose / 9Kaiser Permanente Medical Center / US Public Health Service / American Society for Microbiology / US office of Veterans Affairs / United States Food and Drug Administration / Valley Fever Center for Excellence / 2Southern Arizona Veterans Affairs Health Care System / and 3University of Arizona / Tucson / and 4Mayo Clinic / Arizona Infectious Diseases Society / National Foundation for Infectious Diseases / Infectious Diseases Society of America / Univ. of Arizona / Valley Fever Center for Excellence / Centers for Disease Control and Prevention / 6Kern Medical Center / /

Person

Einstein H. Coccidioidal / Arch Intern / John N. Galgiani / /

/

Position

Cunningham RT / EXECUTIVE / consultant / Fisher / /

Product

itraconazole / Cyclodextrin suspensions / AmBisome / fluconazole / amphotericin B / ketoconazole / /

ProvinceOrState

New Mexico / California / Georgia / Arizona / Texas / /

PublishedMedium

Antimicrobial Agents and Chemotherapy / Clinical Infectious Diseases / /

RadioStation

North Am 2003 / Perlman AM / /

Region

southern New Mexico / southern Arizona / west Texas / central California / /

Technology

Chemotherapy / antibodies / transplantation / /

URL

http /

SocialTag